A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma

Clinical trial NCT05808608 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05808608
Sponsor: Hao Zeng
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma First-line Treatment Non Clear Cell Renal Cell Carcinoma Sarcomatoid Renal Cell Carcinoma

Start date: 2023-11-17
Primary completion: 2026-04-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.